Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Bronchiolitis obliterans is a serious and potentially life-threatening lung disease commonly caused by inhaling diacetyl, a chemical used as an artificial food additive.
The chemical’s vapor is considered “hazardous” by OSHA.
Inhalation of diacetyl vapor is known to cause lung damage resulting in an illness named bronchiolitis obliterans.
Diacetyl vapor has been linked to numerous cases of bronchiolitis obliterans in popcorn production plant workers, earning it the nickname “popcorn lung.”
Bronchiolitis obliterans, or “popcorn lung”, causes chronic scarring and severe narrowing of the lung airways.
If left undiagnosed, continued exposure to diacetyl can cause irreversible lung damage requiring a lung transplant.
It can take months to years for symptoms of lung damage to form after diacetyl fume exposure.
Common symptoms of bronchiolitis obliterans include dry cough, wheezing, shortness of breath, chest pain, and fatigue.
Because these symptoms are common among many chronic lung diseases, it is almost impossible to self-diagnose bronchiolitis obliterans.
If you show signs of any of these symptoms after possible exposure to diacetyl, contact a physician right away.
In addition to severe disability, bronchiolitis obliterans can be fatal.
Early detection of the disease is important and can minimize the possibility of serious treatment.
Because the symptoms are similar to those of many other chronic lung diseases, bronchiolitis obliterans is often misdiagnosed.
Many doctors diagnose bronchiolitis obliterans sufferers with asthma, allergies, COPD, bronchitis, or other lung diseases.
It is important to tell your physician if you believe that you have been exposed to diacetyl at work or even in your own home.
Common medical detection methods include lung capacity tests, biopsy, X-rays, or CT scans.
Pay careful attention to any of the symptoms mentioned in this article if you work in the food manufacturing industry.
TruLaw is talking to individuals diagnosed with bronchiolitis obliterans who believe they were diagnosed from workplace exposure to see if they qualify for a diacetyl lawsuit.
Diacetyl is a toxic chemical but research indicates that many similar chemicals manufacturers have used to replace diacetyl can cause the same lung damage.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
Consumers are advised that about 2,060 cases of Primal Kitchen Avocado Oil (750mL) under three code dates have been recalled by Primal Kitchen because the glass bottles they are packaged in were found likely to break and cause a spill. Announced by the company on
Consumers are advised that Melissa’s brand fresh organic basil in 2.0-ounce and 4.0-ounce packages are now included in a April 19, 2024 recall initiated by Miami, Florida-based Infinite Herbs LLC. The Melissa’s brand portion of the recall covers 96 2.0-ounce packages of fresh organic basil
Fresenius Kabi USA, LLC has announced a corrective Class I recall of an infusion pump software, LVP Software, that runs on the Ivenix Infusion System (IIS). Initiated by the firm on March 7, 2024, the action comes after multiple software anomalies were identified and found